ASTER DM QUALITY CARE Latest Share Price (ASTERDM)
TODAY IN ONE LINE
ASTERDM slipped 0.7% on average volume, lagging Nifty's 0.3% move.
With a market cap of ₹65,737.18 Cr., it trades at a P/E of 122.63. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
ASTER DM QUALITY CARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 71.5% YoY
- ●Healthy Operating MarginsOPM is structurally strong at 15.7%
- ●High Promoter HoldingPromoters hold 53.7% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.15x
- ●Promoter BuyingPromoters increased holdings by 13.33% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 44.6% YoY
- ●Poor Capital ReturnsLow ROE of 8.8%
- ●Expensive ValuationTrading at a high P/E ratio of 103.7x
- ●Rising Receivables vs SalesReceivables grew 35.7% outpacing sales growth of 11.9%
Latest ASTER DM QUALITY CARE News
What changed recently?
Recent events, corporate actions, and announcements.
ASTER DM QUALITY CARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for ASTER DM QUALITY CARE, framed against the sector median so the premium or discount is obvious at a glance.
ASTER DM QUALITY CARE trades at a P/E of 122.63× and P/B of 8.54×, against the Healthcare sector median P/E of 45.85×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
ASTER DM QUALITY CARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for ASTER DM QUALITY CARE — derived from the latest tape, not yesterday's close.
ASTER DM QUALITY CARE last traded at ₹755.05 with an intraday range of ₹747–₹769.6 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹755.05| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 812.63 | +57.58 | +7.63% |
| R3 | 790.03 | +34.98 | +4.63% |
| R2 | 779.82 | +24.77 | +3.28% |
| R1 | 767.43 | +12.38 | +1.64% |
| PIVOT | 757.22 | 2.17 | 0.29% |
| CURRENT | 755.05 | — | — |
| S1 | 744.83 | -10.22 | -1.35% |
| S2 | 734.62 | -20.43 | -2.71% |
| S3 | 722.23 | -32.82 | -4.35% |
| S4 | 699.63 | -55.42 | -7.34% |
ASTERDM is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹757.25–₹768.55
Trading Inside opening range
ASTER DM QUALITY CARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for ASTER DM QUALITY CARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
ASTER DM QUALITY CARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹65,737.18 Cr. and reported EPS of ₹-0.28.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 4,138 | 4,643 ▲ 12.2% |
| Sales Growth YoY %Derived | 11.88% | 12.20% |
| Other Income | 148 | 126 ▼ 15.3% |
| Total Income | 4,287 | 4,769 ▲ 11.2% |
| 938 | 1,049 ▲ 11.8% | |
| Gross ProfitDerived | 3,200 | 3,594 ▲ 12.3% |
| Gross Margin %Derived | 77.33% | 77.41% |
| 2,436 | 2,693 ▲ 10.6% | |
| EBITDA (Operating Profit)Derived | 765 | 901 ▲ 17.9% |
| OPM %Derived | 18.47% | 19.41% |
| 323 | 355 ▲ 9.9% | |
| Profit Before Tax (PBT) | 490 | 607 ▲ 23.8% |
| 134 | 143 ▲ 6.1% | |
| Effective Tax %Derived | 27.42% | 23.50% |
| Profit/Loss from Discontinued Ops | 5,071 | — ▼ 100.0% |
| Total Profit for Period | 5,408 | 427 ▼ 92.1% |
| Less: Non-controlling Interests | 30 | 39 ▲ 29.6% |
| Net Profit (Owner's PAT)Derived | 5,378 | 388 ▼ 92.8% |
| Net Profit Margin %Derived | 129.95% | 8.36% |
| PAT Growth YoY %Derived | 4,059.83% | -92.78% |
| Earnings Per Share (EPS ₹) | 107.66 | 7.49 ▼ 93.0% |
| Diluted Shares Outstanding (Cr) | 50 | 52 ▲ 3.7% |
| Share of Profit from Associates/JVs | -19 | -37 ▼ 95.7% |
| Other Comprehensive Income (Net of Tax) | -2 | 0 ▲ 117.1% |
| Total Expenses (incl. D&A & Interest) | 3,797 | 4,162 ▲ 9.6% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 18.37% | 18.27% |
| Other Cost % of RevenueDerived | 40.48% | 39.74% |
| Interest Coverage (x)Derived | 4.17x | 5.18x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 6,721 | 7,963 ▲ 18.5% | 8,739 ▲ 9.7% | 8,608 ▼ 1.5% | 10,253 ▲ 19.1% | 11,933 ▲ 16.4% | 3,699 ▼ 69.0% | 4,138 ▲ 11.9% | 4,643 ▲ 12.2% | |
| Sales Growth YoY %Derived | — | 18.47% | 9.74% | -1.49% | 19.11% | 16.38% | -69.00% | 11.88% | 12.20% | |
| Other Income | 45 | 35 ▼ 23.8% | 38 ▲ 9.4% | 50 ▲ 32.0% | 51 ▲ 1.4% | 78 ▲ 54.5% | 25 ▼ 68.2% | 148 ▲ 496.5% | 126 ▼ 15.3% | |
| Total Income | 6,767 | 7,997 ▲ 18.2% | 8,776 ▲ 9.7% | 8,658 ▼ 1.3% | 10,304 ▲ 19.0% | 12,011 ▲ 16.6% | 3,724 ▼ 69.0% | 4,287 ▲ 15.1% | 4,769 ▲ 11.2% | |
2,059 | 2,420 ▲ 17.5% | 2,635 ▲ 8.9% | 2,549 ▼ 3.3% | 2,892 ▲ 13.5% | 3,532 ▲ 22.1% | 916 ▼ 74.1% | 938 ▲ 2.5% | 1,049 ▲ 11.8% | ||
| Gross ProfitDerived | 4,662 | 5,543 ▲ 18.9% | 6,103 ▲ 10.1% | 6,060 ▼ 0.7% | 7,362 ▲ 21.5% | 8,401 ▲ 14.1% | 2,783 ▼ 66.9% | 3,200 ▲ 15.0% | 3,594 ▲ 12.3% | |
| Gross Margin %Derived | 69.37% | 69.61% | 69.84% | 70.39% | 71.80% | 70.40% | 75.24% | 77.33% | 77.41% | |
4,049 | 4,680 ▲ 15.6% | 4,845 ▲ 3.5% | 4,997 ▲ 3.1% | 5,878 ▲ 17.6% | 6,836 ▲ 16.3% | 2,205 ▼ 67.7% | 2,436 ▲ 10.5% | 2,693 ▲ 10.6% | ||
| EBITDA (Operating Profit)Derived | 613 | 863 ▲ 40.8% | 1,258 ▲ 45.7% | 1,063 ▼ 15.5% | 1,483 ▲ 39.6% | 1,565 ▲ 5.5% | 578 ▼ 63.1% | 765 ▲ 32.3% | 901 ▲ 17.9% | |
| OPM %Derived | 9.12% | 10.84% | 14.39% | 12.35% | 14.47% | 13.12% | 15.62% | 18.47% | 19.41% | |
612 | 484 ▼ 20.9% | 926 ▲ 91.3% | 911 ▼ 1.6% | 898 ▼ 1.5% | 1,110 ▲ 23.6% | 330 ▼ 70.2% | 323 ▼ 2.3% | 355 ▲ 9.9% | ||
| Profit Before Tax (PBT) | 305 | 411 ▲ 34.4% | 330 ▼ 19.6% | 202 ▼ 39.0% | 636 ▲ 215.7% | 534 ▼ 16.1% | 273 ▼ 49.0% | 490 ▲ 79.8% | 607 ▲ 23.8% | |
26 | 43 ▲ 64.6% | 15 ▼ 64.2% | 27 ▲ 77.0% | 36 ▲ 31.5% | 60 ▲ 66.5% | 57 ▼ 5.2% | 134 ▲ 137.8% | 143 ▲ 6.1% | ||
| Effective Tax %Derived | 8.54% | 10.46% | 4.66% | 13.51% | 5.63% | 11.16% | 20.74% | 27.42% | 23.50% | |
| Profit/Loss from Discontinued Ops | — | — | — | — | — | — | 7 | 5,071 ▲ 73609.3% | — ▼ 100.0% | |
| Total Profit for Period | 282 | 367 ▲ 30.4% | 315 ▼ 14.3% | 178 ▼ 43.5% | 601 ▲ 238.0% | 475 ▼ 20.9% | 212 ▼ 55.5% | 5,408 ▲ 2456.2% | 427 ▼ 92.1% | |
| Less: Non-controlling Interests | 13 | 34 ▲ 167.1% | 38 ▲ 11.3% | 30 ▼ 20.9% | 75 ▲ 149.5% | 51 ▼ 32.6% | 82 ▲ 62.7% | 30 ▼ 63.5% | 39 ▲ 29.6% | |
| Net Profit (Owner's PAT)Derived | 269 | 333 ▲ 23.9% | 277 ▼ 17.0% | 148 ▼ 46.6% | 526 ▲ 256.0% | 425 ▼ 19.2% | 129 ▼ 69.6% | 5,378 ▲ 4059.8% | 388 ▼ 92.8% | |
| Net Profit Margin %Derived | 4.00% | 4.18% | 3.17% | 1.72% | 5.13% | 3.56% | 3.50% | 129.95% | 8.36% | |
| PAT Growth YoY %Derived | — | 23.89% | -16.96% | -46.59% | 256.02% | -19.22% | -69.57% | 4,059.83% | -92.78% | |
| Earnings Per Share (EPS ₹) | 5.32 | 6.59 ▲ 23.9% | 5.54 ▼ 15.9% | 2.96 ▼ 46.6% | 10.53 ▲ 255.7% | 8.51 ▼ 19.2% | 2.59 ▼ 69.6% | 107.66 ▲ 4056.8% | 7.49 ▼ 93.0% | |
| Diluted Shares Outstanding (Cr) | 51 | 51 ▲ 0.0% | 50 ▼ 1.1% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 52 ▲ 3.7% | |
| Share of Profit from Associates/JVs | 2 | -0 ▼ 110.9% | -0 ▲ 24.0% | 4 ▲ 1952.6% | 1 ▼ 84.7% | 1 ▲ 125.9% | -11 ▼ 1029.5% | -19 ▼ 66.8% | -37 ▼ 95.7% | |
| Other Comprehensive Income (Net of Tax) | 10 | 62 ▲ 500.7% | 145 ▲ 131.7% | -50 ▼ 134.4% | 93 ▲ 288.0% | 199 ▲ 112.9% | 46 ▼ 76.7% | -2 ▼ 104.5% | 0 ▲ 117.1% | |
| Total Expenses (incl. D&A & Interest) | 6,461 | 7,587 ▲ 17.4% | 8,446 ▲ 11.3% | 8,457 ▲ 0.1% | 9,668 ▲ 14.3% | 11,477 ▲ 18.7% | 3,451 ▼ 69.9% | 3,797 ▲ 10.0% | 4,162 ▲ 9.6% | |
| Material Cost % of RevenueDerived | — | — | — | — | — | — | — | — | — | |
| Employee Cost % of RevenueDerived | 33.79% | 33.76% | 33.23% | 32.01% | 31.84% | 33.23% | 18.27% | 18.37% | 18.27% | |
| Other Cost % of RevenueDerived | 26.46% | 25.01% | 22.22% | 26.04% | 25.49% | 24.06% | 41.34% | 40.48% | 39.74% | |
| Interest Coverage (x)Derived | 1.71x | 3.11x | 1.87x | 1.52x | 3.28x | 2.38x | 3.25x | 4.17x | 5.18x |
ASTER DM QUALITY CARE segment analysis : revenue and profit mix.
Disclosed business segments at ASTER DM QUALITY CARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
ASTER DM QUALITY CARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for ASTER DM QUALITY CARE.
Our AI distills the core fundamental drivers supporting ASTER DM QUALITY CARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
ASTER DM QUALITY CARE's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 77.4% YoY, demonstrating robust earnings acceleration despite market headwinds.
TTM revenue growth 18.2% outpaces peer average, signaling strong market traction and competitive positioning.
Operating margin 12.91% supports healthy profitability; FY26 margin 21.1% exceeds Apollo and Fortis peers.
Low debt-to-equity 0.0015 and minimal net debt ensure financial stability and operational flexibility.
Diversified four-segment model spanning hospitals, clinics, pharmacies, optical outlets reduces revenue concentration risk.
Key Risks.
P/E ratio 103.69 signals significant overvaluation relative to earnings and peer multiples of 55–70x.
Latest quarterly sales declined 44.63% YoY, indicating severe revenue contraction despite TTM growth.
Latest quarterly profit declined 148.84% YoY, reflecting severe earnings volatility and operational challenges.
ROE 8.84% and ROCE 10.52% fall below peer averages, signaling suboptimal capital deployment efficiency.
FII holdings eased from 23.90% to 19.16%, signaling foreign investor caution and ownership concentration risk.
Flip Conditions.
Valuation risk. a P/E above 159 (~3.5× the sector multiple of 45.9) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
ASTER DM QUALITY CARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — ASTER DM QUALITY CARE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
ASTER DM QUALITY CARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for ASTER DM QUALITY CARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
ASTER DM QUALITY CARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for ASTER DM QUALITY CARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in ASTER DM QUALITY CARE stood at 61.9% of traded volume, against a 20-day average of 58.3%.
ASTER DM QUALITY CARE announcements: results, concalls, ratings, M&A.
Filings ASTER DM QUALITY CARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
ASTER DM QUALITY CARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 215 documents below.
General Updates
Aster DM Quality Care Limited has informed the Exchange about issue of an Addendum to the Notice of 18th Annual General Meeting of the Company.
Credit Rating- Revision
Aster DM Quality Care Limited has informed the Exchange about revision in Credit Rating of a Material Subsidiary
Copy of Newspaper Publication
Aster DM Quality Care Limited has informed the Exchange about Copy of Newspaper Publication - Dispatch of Notice of 18th Annual General Meeting and…
Updates
Aster DM Quality Care Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for Financial Year 2025-26'.
Shareholders meeting
Aster DM Quality Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
Investor decks & rating reports.
ASTER DM QUALITY CARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue ASTER DM QUALITY CARE has declared, sequenced by announce and record date.
ASTER DM QUALITY CARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
ASTER DM QUALITY CARE insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in ASTER DM QUALITY CARE as reported to SEBI — buying and selling signals from the people who know the business best.
ASTER DM QUALITY CARE insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Union (Mauritius) Holdings Limited | Insider | 20 Mar 2025 | buy | +2.00 Cr | ₹865.16 Cr. | ₹433.00 |
| Union Investments Private Limited | Insider | 20 Mar 2025 | buy | +2.00 Cr | ₹865.16 Cr. | ₹433.00 |
| Union Investments Private Limited | Insider | 07 Mar 2025 | buy | +8.51 Cr | ₹3,552.37 Cr. | ₹417.45 |
| Union Investments Private Limited | Insider | 04 Mar 2025 | buy | +18.69 Cr | ₹7,362.04 Cr. | ₹394.00 |
| Union (Mauritius) Holdings Limited | Insider | 04 Mar 2025 | buy | +2.00 Cr | ₹787.23 Cr. | ₹394.00 |
About ASTER DM QUALITY CARE: business, sector, key facts.
What ASTER DM QUALITY CARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
ASTER DM QUALITY CARE operates in the Hospital industry under the Healthcare sector, listed as NSE: ASTERDM, BSE: 540975.
Aster DM Healthcare Limited is a prominent healthcare provider operating across a wide geographical expanse. Its services span several countries in the Middle East and South Asia, including India, the United Arab Emirates, Qatar, Oman, Saudi Arabia, Jordan, Kuwait, Bahrain, and Mauritius. This extensive reach establishes Aster DM as a significant player in the international healthcare market, delivering services to a diverse patient population.
The company's business is structured around four key segments: Hospitals, Clinics, Retail Pharmacies, and Others. The Hospitals segment encompasses the operation of large-scale hospitals, often including integrated in-house pharmacies to provide comprehensive patient care within a single facility. Similarly, the Clinics segment focuses on smaller-scale clinics, also frequently with integrated pharmacies for convenient access to medications.
Aster DM's Retail Pharmacies segment represents a substantial portion of its business. This encompasses a network of both physical retail pharmacies and online pharmacy services, extending access to medications and healthcare products beyond the company's hospital and clinic settings. The addition of optical outlets further diversifies this segment, offering comprehensive eye care and related products to a wider customer base.
The "Others" segment encompasses a variety of supporting services and business activities. This includes healthcare consultancy, offering specialized advice and expertise to other healthcare organizations or institutions, as well as other ancillary services that support the core operations of the company’s hospital, clinic, and retail pharmacy networks. This diversified approach allows Aster DM to expand its revenue streams and offers opportunities for growth and strategic partnerships.
In summary, Aster DM Healthcare Limited's business model centers around providing a comprehensive range of healthcare services, from hospital-based care to retail pharmacy access, across multiple countries. Its diversified business structure, coupled with its international reach, positions the company for continued growth and influence in the global healthcare landscape. The company's long history, beginning in 1987, demonstrates its enduring commitment to delivering quality healthcare services and its ability to adapt and expand within a dynamic market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- DR AGARWALS HEALTH CARE L (AGARWALEYE) Share PricePeer
- APOLLO HOSPITALS ENTER L (APOLLOHOSP) Share PricePeer
- ARTEMIS MED SERVICE (ARTEMISMED) Share PricePeer
- FORTIS HEALTHCARE (FORTIS) Share PricePeer
- GPT HEALTHCARE (GPTHEALTH) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about ASTER DM QUALITY CARE (ASTERDM).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of ASTER DM QUALITY CARE (ASTERDM)?
The current share price of ASTER DM QUALITY CARE (ASTERDM) is ₹755.05. Today, the stock has declined by ₹5.60 (0.74%), trading in a range of ₹747.00 to ₹769.60. The stock opened at ₹761.10 with a trading volume of 16,16,337 shares.
02Is ASTER DM QUALITY CARE stock a good investment for long-term?
ASTER DM QUALITY CARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹65,737.18 Cr., P/E ratio of 122.63, ROE of 8.84%, and ROCE of 12.97%. The dividend yield stands at 0.4%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of ASTER DM QUALITY CARE stock?
The 52-week high price of ASTER DM QUALITY CARE (ASTERDM) is ₹891.30, while the 52-week low is ₹519.10. Currently trading at ₹755.05, the stock is 45.45% above its 52-week low and 15.29% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy ASTER DM QUALITY CARE stock at the current price?
Whether to buy ASTER DM QUALITY CARE stock at ₹755.05 depends on multiple factors. The stock is currently trading with a P/E ratio of 122.63 and P/B ratio of 8.54. Today's performance shows a loss of 0.74%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of ASTER DM QUALITY CARE and when is the next dividend?
ASTER DM QUALITY CARE offers a dividend yield of 0.4%, which means for every ₹100 invested at the current price of ₹755.05, you can expect to receive approximately ₹0.40 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of ASTER DM QUALITY CARE?
ASTER DM QUALITY CARE's key financial metrics include: P/E Ratio: 122.63, P/B Ratio: 8.54, ROE: 8.84%, ROCE: 12.97%, Dividend Yield: 0.4%, EPS: ₹-0.28, Book Value: ₹93.29, and Debt-to-Equity: 0.15. The company's market cap stands at ₹65,737.18 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is ASTER DM QUALITY CARE stock performing today in the market?
ASTER DM QUALITY CARE stock opened at ₹761.10 and is currently trading at ₹755.05, showing a decline of ₹5.60 (0.74%). The intraday high is ₹769.60 and low is ₹747.00. The trading volume stands at 16,16,337 shares, indicating strong market participation today.
08What is the P/E ratio of ASTER DM QUALITY CARE and what does it indicate?
ASTER DM QUALITY CARE has a Price-to-Earnings (P/E) ratio of 122.63, which means investors are willing to pay 122.63 for every ₹1 of earnings. With an EPS of ₹-0.28, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about ASTER DM QUALITY CARE (ASTERDM) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.